Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.

by Matilda Holm, Mayank Saraswat, Sakari Joenväärä, Ari Ristimäki, Caj Haglund, Risto Renkonen
Published 2018-01-01

Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival

by Matilda Holm, Mayank Saraswat, Sakari Joenväärä, Hanna Seppänen, Risto Renkonen, Caj Haglund
Published 2020-06-01

Plasma protein expression differs between colorectal cancer patients depending on primary tumor location

by Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Tiialotta Tohmola, Ari Ristimäki, Risto Renkonen, Caj Haglund
Published 2020-07-01

Differences and overlap in plasma protein expression during colorectal cancer progression

by Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Tiialotta Tohmola, Ari Ristimäki, Risto Renkonen, Caj Haglund
Published 2019-08-01

N-glycomic profiling of colorectal cancer according to tumor stage and location.

by Matilda Holm, Pirjo Nummela, Annamari Heiskanen, Tero Satomaa, Tuomas Kaprio, Harri Mustonen, Ari Ristimäki, Caj Haglund
Published 2020-01-01

Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome

by Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Harri Mustonen, Tiialotta Tohmola, Ari Ristimäki, Risto Renkonen, Caj Haglund
Published 2019-12-01

Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing.

by Matilda Holm, Emma Andersson, Emerik Osterlund, Ali Ovissi, Leena-Maija Soveri, Anna-Kaisa Anttonen, Soili Kytölä, Kristiina Aittomäki, Pia Osterlund, Ari Ristimäki
Published 2020-01-01